Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

The sensor accurately measures thallium ions in solutions with high selectivity.

Hair can measure exposure to radioisotopes.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Galectin-1 helps in RNA processing in cell nuclei.

Analog 23 is a promising compound for prostate cancer treatment.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

A new compound was effective for imaging prostate cancer in rats.

New laser particles can track thousands of cells in 3D models, improving single-cell analysis.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Blocking certain immune signals can reduce skin damage from radiation therapy.

New steroids were effective in blocking male hormone receptors in hamster prostates.